Minova Life Science

Zitrobid 250/500 Tablets & 200 Suspension – Azithromycin for Bacterial Infections

Zitrobid 250/500 Tablets and Zitrobid 200 Suspension containing Azithromycin by Minova Life Sciences – antibiotic treatment for bacterial infections.

🧬 Introduction

Zitrobid is a powerful macrolide antibiotic range from Minova Life Sciences, formulated with Azithromycin to fight a wide spectrum of bacterial infections. Available in both tablet and oral suspension forms, Zitrobid is ideal for treating upper and lower respiratory infections, ENT infections, and skin conditions.

It is available in:

  • Zitrobid 250 mg Tablets

  • Zitrobid 500 mg Tablets

  • Zitrobid 200 mg Suspension (15ml/30ml)


⚙️ Pharmacokinetics & Bioavailability

Azithromycin is rapidly absorbed, achieving peak plasma levels within 2–3 hours. Its long half-life allows once-daily dosing and ensures sustained tissue penetration, making it ideal for short-course therapies. It is excreted primarily via bile in unchanged form.


📌 Indications & Uses

Zitrobid is indicated for the treatment of:

  • Pharyngitis & Tonsillitis

  • Acute Bronchitis & Pneumonia

  • Skin & Soft Tissue Infections

  • Sinusitis

  • Otitis Media

  • Sexually Transmitted Diseases (Chlamydia)

  • Typhoid Fever (off-label)

Especially useful for:

  • Children (Suspension)

  • Adults (Tablets)


🕒 Dosage & Administration

📦 Zitrobid 250 / 500 Tablets:

  • Usual adult dose: 500mg once daily for 3 days, or as per physician guidance.

  • In certain conditions, a single 1000mg dose may be prescribed.

🍓 Zitrobid 200 Suspension:

  • For children: Dose based on body weight (10mg/kg once daily) for 3–5 days

  • Shake well before use

  • Store in a cool, dry place


Contraindications

  • Known allergy to Azithromycin or macrolides

  • Hepatic impairment

  • Caution in QT prolongation or heart arrhythmia patients


⚠️ Warnings & Precautions

  • May interact with antacids (separate doses by 2 hours)

  • Monitor liver enzymes in long-term use

  • Avoid in severe renal impairment

  • Not recommended in infants <6 months (suspension)


Adverse Effects

Common:

  • Nausea, vomiting

  • Diarrhea

  • Abdominal discomfort

Rare:

  • Elevated liver enzymes

  • Hearing loss (high doses)

  • Allergic rash or anaphylaxis (very rare)


💊 Drug Interactions

  • Antacids: Reduce absorption of Azithromycin

  • Warfarin: Increased bleeding risk

  • Cyclosporine: May increase serum levels

  • Digoxin & Ergot derivatives: Avoid combination


🧊 Storage Conditions

  • Store below 25°C

  • Keep away from light & moisture

  • Keep suspension tightly closed after opening

  • Use suspension within 5 days of preparation


📈 Franchise & Distribution Opportunity

Minova Life Sciences offers PCD pharma franchise rights for Zitrobid Azithromycin range across India.

✅ High-demand antibiotic product
✅ Promotional support & MR bag
✅ Monopoly-based PCD rights
✅ Attractive margins & fast delivery

🚀 Interested in starting a pharma franchise with Zitrobid tablets or suspension?
👉 Click Here to Apply for Franchise


Conclusion

Zitrobid 250/500 Tablets and 200mg Suspension represent a trusted and potent antibiotic choice for a wide range of infections. With Azithromycin’s proven efficacy and once-daily convenience, it’s a go-to option for both pediatric and adult patients. Join hands with Minova Life Sciences to distribute Zitrobid in your area and become a part of a trusted healthcare network.

✅ Trusted Pharmaceutical Company in India

Since 2007, we have been at the forefront of scientific research and development, consistently delivering breakthrough medicines and therapies that address critical medical challenges. Our experienced team of experts works tirelessly to ensure that our products meet the highest standards of efficacy, safety, and compliance.

📞 Contact Us

📞 Phone: +91-9845329972
📧 Email: info@minovalifesciences.com
🌐 Website: Minova Life Sciences

 

6 thoughts on “Zitrobid 250/500 Tablets & 200 Suspension – Azithromycin for Bacterial Infections”

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top